46 results

• Metformin No Better Than Placebo at Treating Diabetes During Pregnancy: Study

  October 5, 2023

  Martha Garcia

  A new study warns that metformin is no better at controlling blood glucose levels during pregnancy than a placebo, and may carry and increased risk of low birth weight children.

• Nitrosamines Problems Are More Widespread in Drugs Than FDA Anticipated: Report

  November 1, 2022

  Irvin Jackson

  The FDA has been caught off-guard by the number of drugs being recalled for nitrosamine contamination and is likely to update a 2020 guidance to better address the problem according to a recent report.

• Metformin Use Among Men Linked To Increased Risk of Birth Defects in Their Children

  March 30, 2022

  Martha Garcia

  The findings of a new study suggest that the children of men who used metformin just before conception face an increased risk of birth defects.

• Generic Metformin Recall Issued Over NDMA Contamination

  January 3, 2022

  Irvin Jackson

  Dozens of batches of generic metformin are being recalled due to the presence of NDMA; a cancer-causing chemical byproduct which has led to numerous drug recalls in recent years.

• Lupin Irebesartan Recall Issued Over Cancer Causing N-nitrosoirbesartan Contamination

  October 15, 2021

  Irvin Jackson

  Nearly 80 lots of Irbesartan and Irbesartan/HCTZ combination tablets are being recalled due to the presence of a potentially cancer-causing chemical.

• Valsartan Lawsuit Alleges Toxic Contamination Led to 8 Different Cancer Diagnoses

  August 6, 2021

  Irvin Jackson

  A valsartan lawsuit claims the recalled hypertension drug led to eight cancer diagnoses for a New York man.

• Generic Valsartan Lawsuit Alleges NDMA Exposure Led To Prostate Cancer

  July 26, 2021

  Irvin Jackson

  A product liability lawsuit claims years of generic valsartan use led to the development of prostate cancer due to the presence of NDMA and other impurities.

• Viona Pharmaceuticals Metformin Recall Issued Over High Levels of NDMA Linked to Cancer Risk

  June 14, 2021

  Irvin Jackson

  Two lots of generic metformin are being recalled by the FDA after the agency detected high levels of NDMA; a cancer-causing chemical which sparked massive Zantac and valsartan recalls in recent years.

• NDMA Problems Leads To Additional Metformin Recalls

  January 27, 2021

  Irvin Jackson

  Another Nostrum generic metformin recall expansion was announced after the company again found high levels of NDMA in the diabetes drugs.

• Metformin Contamination Problems Result in Expanded Recall By Nostrum Laboratories

  January 6, 2021

  Irvin Jackson

  A previous metformin recall has been expanded after high levels of NDMA were detected in an additional lot of the diabetes drug tablets.